Blog
Banco Itau (ITUB) Moves to Strong Buy: Rationale Behind the Upgrade
Banco Itau (ITUB) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates
Zacks Initiates Coverage of Peoples Bancorp With Neutral Recommendation
Zacks Investment Research has recently initiated coverage of Peoples Bancorp of North Carolina, Inc. PEBK, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a
ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up
Esperion Therapeutics ESPR announced that it has nominated ESP-2001, a highly specific allosteric ATP citrate lyase (“ACLY”) inhibitor, as its new preclinical development candidate for the treatment
Can Bloom Energy's Combustion-Free Power Drive Long-Term Growth?
Bloom Energy Corporation BE, by utilizing its solid oxide fuel cell technology, delivers reliable, combustion-free power to its customers. Unlike traditional fossil-fuel-based generation, Bloom
Netflix Gears Up to Report Q3 Earnings: Buy, Sell or Hold NFLX Stock?
Netflix NFLX is slated to report third-quarter 2025 results on Oct. 21. For the third quarter, Netflix projects revenues of $11.526 billion, suggesting year-over-year growth of approximately 17% on
Is Upstart's Diversification Strategy the Key to Lasting Growth?
Upstart Holdings UPST is broadening its reach well beyond personal loans, using its AI-powered lending platform to tap new segments like auto loans, home equity and small-dollar credit. In the
American Express Q3 Earnings Beat Estimates on Rising Network Volume
American Express Company AXP reported third-quarter 2025 earnings per share (EPS) of $4.14, which beat the Zacks Consensus Estimate by 4.6%. The bottom line climbed 19% year over year.
Total
Regions Financial Q3 Earnings Top on High NII & Fee Income, Stock Up
Regions Financial Corporation’s RF third-quarter 2025 adjusted earnings per share of 63 cents beat the Zacks Consensus Estimate of 60 cents. This compares favorably with earnings of 57 cents per
Korn/Ferry (KFY) Could Be a Great Choice
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is
Why National Bank Holdings (NBHC) is a Great Dividend Stock Right Now
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from
Why Unitil (UTL) is a Top Dividend Stock for Your Portfolio
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your
Brookfield Infrastructure Partners (BIP) Could Be a Great Choice
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from
Cullen/Frost Bankers (CFR) Could Be a Great Choice
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent
Why Eagle Bancorp Montana, Inc. (EBMT) is a Top Dividend Stock for Your Portfolio
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is
Orrstown Financial Services (ORRF) Could Be a Great Choice
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent
Why United Community Banks (UCB) is a Great Dividend Stock Right Now
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is
Why Southern Missouri Bancorp (SMBC) is a Top Dividend Stock for Your Portfolio
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is
Are You Looking for a High-Growth Dividend Stock?
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is
Why Investar (ISTR) is a Top Dividend Stock for Your Portfolio
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your
Are You Looking for a High-Growth Dividend Stock?
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your
Are You Looking for a High-Growth Dividend Stock?
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from
Marathon Petroleum (MPC) is a Top Dividend Stock Right Now: Should You Buy?
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from
Why Heritage Financial (HFWA) is a Top Dividend Stock for Your Portfolio
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from
NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs
Novo Nordisk NVO shares fell roughly 4% in pre-market trading today after U.S. President Donald Trump signaled potential steep price cuts for the company’s blockbuster GLP-1 RA drugs during a White


